Setting A1c Goals (Melvin)
Endocrinology
Curriculum:
Diabetes: Setting Goals and Initiating Therapy
Diabetes: Setting Goals and Initiating Therapy
Credits:
0.5 ANCC Contact Hours 0.5 AMA PRA Category 1 Credit(s) ™
0.5 ANCC Contact Hours 0.5 AMA PRA Category 1 Credit(s) ™
Launch Date:
June 03, 2014
June 03, 2014
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Family practitioners, primary care physicians, endocrinologists, nurse practitioners, physician's assistants, and nurses with an interest in diabetes.
Relevant Terms:
Diabetes
Mark E. Molitch, MD
Mark E. Molitch, MD
Martha Leland Sherwin Professor of Medicine
Department of Endocrinology
Feinberg School of Medicine
Northwestern University
Chicago, IL
Bio
Mark E Molitch, MD is a Martha Leland Sherwin Professor in Medicine/Endocrinology at the Northwestern University Feinberg School of Medicine. Dr. Molitch has participated in clinical research for several years in the area of diabetes, focusing on diabetes complications and treatment of diabetic kidney disease, and has participated in many NIH-sponsored multicenter trials, including the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study; the Diabetes Prevention Program; and the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial. In addition to editing eight books and journal volumes, Dr. Molitch has authored or coauthored more than 400 original papers, review articles, book chapters, case reports and other publications.
Dr. Molitch was named “Outstanding Physician Educator in the Field of Diabetes” in 1997 by the ADA and he has been awarded the “Distinguished Educator Award” of The Endocrine Society for 2013. He was elected to the Council of The Endocrine Society from 2007 to 2010 and recently completed a 3 year term as the Chair of The Endocrine Society’s Clinical Endocrinology Update in 2012.
| 1. | Discuss current treatment goals for initiation and/or intensification of treatment to meet the individual glycemic needs, priorities, and preferences of each patient | 2. | Initiate or combine therapies to efficiently attain A1C goals while reducing the risk of weight gain and hypoglycemia |
| 1. | Discuss current treatment goals for initiation and/or intensification of treatment to meet the individual glycemic needs, priorities, and preferences of each patient |
| 2. | Initiate or combine therapies to efficiently attain A1C goals while reducing the risk of weight gain and hypoglycemia |
Melvin: Setting A1c Goals
*Please note that participation in this activity is available for CME and CNE credits only. MOC credits will not be granted solely for participation in these online activities. MOC credit is only available to those participating in a private program that includes two additional QI components.
FACULTY
Mark E. Molitch, MD
Professor of Medicine
Division of Endocrinology, Metabolism, and Molecular Medicine
Northwestern University
Feinberg School of Medicine
Chicago, Illinois
This PI-CME program is designed to meet the educational needs of primary care physicians, endocrinologists, diabetologists, nurses, pharmacists, and other healthcare practitioners involved in the treatment of patients with type 2 diabetes.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group will designate a maximum of 0.5 AMA PRA Category 1 Credits™ for this case study.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
NURSING CREDIT INFORMATION
Purpose:
This program would be beneficial for nurses involved in the management of patients with diabetes and would help them to implement an individualized plan for their patients.
CNE Credits:
Each activity is accredited for 0.5 ANCC Contact Hour(s)
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 0.5 contact hour(s) of continuing nursing education of RNs and APNs per activity.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Dr. Mark Molitch receives consulting fees from Abbott Labs, Astra-Zeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novo-Nordisk, and Novartis; and has contracted research with Bayer, Novo-Nordisk, Novartis, Reata, Tercica. He would also like to disclose that his wife has ownership interest in Amgen. MLG Course Reviewer
Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania
UMA/CCM Nurse Reviewer
Margaret Governo, EdD, APRN BC
CCM Lead Nurse Planner
Ultimate Medical Academy
MLG Course Reviewer - - Dr. Katherine Galluzzi has no relevant financial relationships to disclose.
CCM/UMA Lead Nurse Planner - - Margaret Governo, EdD, APRN BC has disclosed no significant financial relationships.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, Vice President of Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, Dr. Molitch may mention the use of medications for both FDA-approved and non-approved indications
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Submit the evaluation form to the Med Learning Group.
You will receive your certificate via email within 30 days.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at info@medlearninggroup.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
Sponsored by Med Learning Group
This activity was co-provided by Ultimate Medical Academy/CCM.
Supported by an Educational Grant from Lilly USA, LLC and
Takeda Pharmaceuticals International, Inc.
Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.
Copyright © 2014 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 5.0+ for Mac OSX 10.5 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
